Sopharma AD (BUL:SFA)
Bulgaria · Delayed Price · Currency is BGN · Price in EUR 1.925
+0.035 (1.85%)
At close: Jul 31, 2026
Sopharma AD Financials Overview
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 1,398 | 1,347 | 1,101 | 965.71 | 854.43 | 824 |
Revenue Growth | 20.06% | 22.31% | 14.02% | 13.02% | 3.69% | 11.47% |
Gross Profit Gross Profit Growth | 341.26 | 319.77 | 236.88 | 213.98 | 186.77 | 177.42 |
Operating Income Operating Income Growth | 76.68 | 68.99 | 40.44 | 47.7 | 43.89 | 31.44 |
Net Income Net Income Growth | 80.63 | 68.3 | 39.12 | 49.07 | 36.36 | 45.77 |
Earnings Per Share EPS Growth | 0.23 | 0.20 | 0.08 | 0.12 | 0.10 | 0.12 |
EPS Growth | 172.92% | 153.50% | -33.17% | 21.08% | -19.76% | 199.73% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 22.14 | 36.63 | 18.3 | 65.89 | 10.15 | 19.29 |
Total Debt Total Debt Growth | 298.99 | 313.5 | 246.49 | 179.38 | 144.81 | 169.07 |
Net Cash (Debt) Net Cash Growth | -276.85 | -276.88 | -228.19 | -113.49 | -134.66 | -149.78 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -0.78 | -0.81 | -0.46 | -0.27 | -0.36 | -0.40 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 42.54 | 9.49 | 39.33 | 23.02 | 56.27 | -38.85 |
Capital Expenditures CapEx Growth | -23.14 | -23.02 | -17.37 | -12.47 | -9.89 | -10.41 |
Free Cash Flow Free Cash Flow Growth | 19.4 | -13.53 | 21.96 | 10.55 | 46.38 | -49.25 |
Free Cash Flow Growth | -77.42% | - | 108.11% | -77.25% | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 24.41% | 23.75% | 21.51% | 22.16% | 21.86% | 21.53% |
Operating Margin | 5.49% | 5.12% | 3.67% | 4.94% | 5.14% | 3.82% |
Pretax Margin | 6.53% | 5.97% | 4.29% | 5.89% | 5.09% | 6.06% |
Profit Margin | 5.77% | 5.07% | 3.55% | 5.08% | 4.25% | 5.55% |
FCF Margin | 1.39% | -1.00% | 1.99% | 1.09% | 5.43% | -5.98% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 3, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Dividend Per Share Dividend Per Share Growth | 0.056 | - | 0.027 | 0.169 | 0.102 |
Dividend Per Share Growth | 80.70% | - | -84.29% | 65.03% | - |
Dividend Yield | 1.52% | - | 2.88% | 19.11% | 18.82% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 3, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 8.36 | 10.83 | 12.52 | 9.47 | 7.61 | 6.21 |
Forward PE | - | 12.83 | 12.83 | 13.24 | 10.31 | 13.55 |
P/FCF Ratio | 52.32 | - | 22.31 | 44.03 | 5.97 | - |
PS Ratio | 0.73 | 0.55 | 0.45 | 0.48 | 0.32 | 0.35 |